-
PET imaging using the novel radioligand FDDNP shows promise in the early diagnosis of Alzheimer's disease.
-
Approximately one half of patients who meet current criteria for the diagnosis of primary Sjögren syndrome have clinical or laboratory evidence for peripheral neuropathy.
-
Two large independent studies raise further concern over increased risk of serious cardiac valve disease in patients treated for Parkinson's disease with ergoline dopamine agonists, pergolide and cabergoline.
-
Patients treated with the ketogenic diet for more than 6 years showed sustained seizure reduction (90% decrease in seizure frequency) with few serious side effects.
-
-
The use of magnesium may reduce ischemic complications after SAH and thereby may reduce the risk of poor outcome after SAH, but as yet, the evidence for its use in clinical practice is inconclusive.
-
Atorvastatin reduces cholesterol levels and improves cognition in Alzheimer’s disease patients.
-
Progression of the cord lesion and lack of steroid response prompted antibiotic treatment for Whipple’s disease.
-
Nesiritide, Scios' intravenous recombinant form of human B-type naturetic peptide, has been widely used for the treatment of congestive heart failure in hospitalized patients.
-
